Literature DB >> 24478497

Toll-like receptor 2 in serum: a potential diagnostic marker of prosthetic joint infection?

Emanuela Galliera1, Lorenzo Drago, Christian Vassena, Carlo Romanò, Monica Gioia Marazzi, Lucia Salcito, Massimiliano M Corsi Romanelli.   

Abstract

Prosthetic joint infection (PJI) is a severe complication of arthroplasty and is still lacking diagnostic gold standards. PJI patients display high Toll-like receptor 2 (TLR2) serum levels, correlating with canonical inflammatory markers (C-reactive protein [CRP], interleukin 6 [IL-6], tumor necrosis factor alpha [TNF-α], and IL-1). Therefore, TLR2 serum levels could be considered a new potential diagnostic tool in the early detection of PJI.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24478497      PMCID： PMC3911304          DOI： 10.1128/JCM.02727-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  26 in total

1.  The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey.

Authors:  J E Phillips; T P Crane; M Noy; T S J Elliott; R J Grimer
Journal:  J Bone Joint Surg Br       Date:  2006-07

Review 2.  Toll-like receptors and innate immunity.

Authors:  Himanshu Kumar; Taro Kawai; Shizuo Akira
Journal:  Biochem Biophys Res Commun       Date:  2009-08-15       Impact factor: 3.575

3.  The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization.

Authors:  Kevin J Bozic; Michael D Ries
Journal:  J Bone Joint Surg Am       Date:  2005-08       Impact factor: 5.284

4.  Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties.

Authors:  M J Spangehl; B A Masri; J X O'Connell; C P Duncan
Journal:  J Bone Joint Surg Am       Date:  1999-05       Impact factor: 5.284

5.  Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group.

Authors:  B L Atkins; N Athanasou; J J Deeks; D W Crook; H Simpson; T E Peto; P McLardy-Smith; A R Berendt
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

Review 6.  Diagnosis of periprosthetic infection.

Authors:  Thomas W Bauer; Javad Parvizi; Naomi Kobayashi; Viktor Krebs
Journal:  J Bone Joint Surg Am       Date:  2006-04       Impact factor: 5.284

7.  Differential expression of toll-like receptor genes: sepsis compared with sterile inflammation 1 day before sepsis diagnosis.

Authors:  Matthew E Lissauer; Steven B Johnson; Grant V Bochicchio; Carinda J Feild; Alan S Cross; Jeffrey D Hasday; Craig C Whiteford; William A Nussbaumer; Michael Towns; Thomas M Scalea
Journal:  Shock       Date:  2009-03       Impact factor: 3.454

8.  icaA is not a useful diagnostic marker for prosthetic joint infection.

Authors:  Kristi L Frank; Arlen D Hanssen; Robin Patel
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 9.  Prosthetic joint infections: microbiology, diagnosis, management and prevention.

Authors:  Silvano Esposito; Sebastiano Leone
Journal:  Int J Antimicrob Agents       Date:  2008-07-09       Impact factor: 5.283

Review 10.  The function of TLR2 during staphylococcal diseases.

Authors:  Bénédicte Fournier
Journal:  Front Cell Infect Microbiol       Date:  2013-01-04       Impact factor: 5.293
View more
  8 in total

1.  TLR9 gene polymorphism -1486T/C (rs187084) is associated with uterine cervical neoplasm in Mexican female population.

Authors:  Cecilia Martínez-Campos; Margarita Bahena-Román; Kirvis Torres-Poveda; Ana I Burguete-García; Vicente Madrid-Marina
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-17       Impact factor: 4.553

Review 2.  Diagnosing Periprosthetic Joint Infection: a Scoping Review.

Authors:  Aaron Gazendam; Thomas J Wood; Daniel Tushinski; Kamal Bali
Journal:  Curr Rev Musculoskelet Med       Date:  2022-04-04

3.  The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease Biomarker.

Authors:  Md Jakir Hossain; Elena Morandi; Radu Tanasescu; Nanci Frakich; Marzia Caldano; David Onion; Tola A Faraj; Clett Erridge; Bruno Gran
Journal:  Front Immunol       Date:  2018-03-14       Impact factor: 7.561

4.  Excellent Diagnostic Characteristics for Ultrafast Gene Profiling of DEFA1-IL1B-LTF in Detection of Prosthetic Joint Infections.

Authors:  Regina Fillerova; Jiri Gallo; Martin Radvansky; Veronika Kraiczova; Milos Kudelka; Eva Kriegova
Journal:  J Clin Microbiol       Date:  2017-06-21       Impact factor: 5.948

5.  Procoagulatory state in inflammatory bowel diseases is promoted by impaired intestinal barrier function.

Authors:  Luca Pastorelli; Elena Dozio; Laura Francesca Pisani; Massimo Boscolo-Anzoletti; Elena Vianello; Nadia Munizio; Luisa Spina; Gian Eugenio Tontini; Flora Peyvandi; Massimiliano Marco Corsi Romanelli; Maurizio Vecchi
Journal:  Gastroenterol Res Pract       Date:  2015-02-12       Impact factor: 2.260

6.  Soluble Toll-Like Receptors 2 and 4 in Cerebrospinal Fluid of Patients with Acute Hydrocephalus following Aneurysmal Subarachnoid Haemorrhage.

Authors:  Bartosz Sokół; Norbert Wąsik; Roman Jankowski; Marcin Hołysz; Barbara Więckowska; Paweł Jagodziński
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

7.  Plasmatic Soluble Receptor for Advanced Glycation End Products as a New Oxidative Stress Biomarker in Patients with Prosthetic-Joint-Associated Infections?

Authors:  Luca Massaccesi; Barbara Bonomelli; Monica Gioia Marazzi; Lorenzo Drago; Massimiliano Marco Corsi Romanelli; Daniela Erba; Nadia Papini; Alessandra Barassi; Giancarlo Goi; Emanuela Galliera
Journal:  Dis Markers       Date:  2017-12-13       Impact factor: 3.434

8.  The serum level of D-Dimer is not suitable for distinguishing between prosthetic joint infection and aseptic loosening.

Authors:  Jincheng Huang; Yongchao Zhang; Zhen Wang; Yonghui Dong; Yongqiang Zhao; Jia Zheng; Hongkai Lian; Yi Jin
Journal:  J Orthop Surg Res       Date:  2019-11-29       Impact factor: 2.359
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.